Market cap of G Medical Innovations Holdings Ltd [GMVD] reaches 6.88M – now what?


G Medical Innovations Holdings Ltd [NASDAQ: GMVD] closed the trading session at $0.51 on 07/18/22. The day’s price range saw the stock hit a low of $0.48, while the highest price level was $0.94. The company report on July 13, 2022 that G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick results.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The first 7 new health testing kits covering Food sensitivity (96 and 208 types of food), indoor/outdoor allergies, Thyroid functioning, testosterone levels, HbA1C and HPV tests will be available for purchasing by consumers during Q3-2022 online as well as at popular retail locations and pharmacies.

The tests offered to the consumers utilize FDA registered components.

The stocks have a year to date performance of -69.43 percent and weekly performance of -45.30 percent. The stock has been moved at -85.49 percent over the last six months. The stock has performed -21.45 percent around the most recent 30 days and changed -67.06 percent over the most recent 3-months.

If compared to the average trading volume of 2.45M shares, GMVD reached to a volume of 7509937 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about G Medical Innovations Holdings Ltd [GMVD]:

The Average True Range (ATR) for G Medical Innovations Holdings Ltd is set at 0.17, with the Price to Sales ratio for GMVD stock in the period of the last 12 months amounting to 1.36. The Price to Book ratio for the last quarter was 2.03.

GMVD stock trade performance evaluation

G Medical Innovations Holdings Ltd [GMVD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -45.30. With this latest performance, GMVD shares dropped by -21.45% in over the last four-week period, additionally sinking by -85.49% over the last 6 months – not to mention a drop of -87.14% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GMVD stock in for the last two-week period is set at 39.67, with the RSI for the last a single of trading hit 34.44, and the three-weeks RSI is set at 41.42 for G Medical Innovations Holdings Ltd [GMVD]. The present Moving Average for the last 50 days of trading for this stock 0.6945, while it was recorded at 0.8272 for the last single week of trading, and 1.8815 for the last 200 days.

G Medical Innovations Holdings Ltd [GMVD]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and G Medical Innovations Holdings Ltd [GMVD] shares currently have an operating margin of -222.80 and a Gross Margin at +19.77. G Medical Innovations Holdings Ltd’s Net Margin is presently recorded at -291.78.

G Medical Innovations Holdings Ltd [GMVD]: Insider Ownership positions

There are presently around $0 million, or 2.27% of GMVD stock, in the hands of institutional investors. The top three institutional holders of GMVD stocks are: SCHONFELD STRATEGIC ADVISORS LLC with ownership of 117,100, which is approximately -6.17% of the company’s market cap and around 38.41% of the total institutional ownership; JPMORGAN CHASE & CO, holding 60,164 shares of the stock with an approximate value of $56000.0 in GMVD stocks shares; and CITADEL ADVISORS LLC, currently with $47000.0 in GMVD stock with ownership of nearly New of the company’s market capitalization.

8 institutional holders increased their position in G Medical Innovations Holdings Ltd [NASDAQ:GMVD] by around 118,892 shares. Additionally, 6 investors decreased positions by around 165,413 shares, while 0 investors held positions by with 72,416 shares. The mentioned changes placed institutional holdings at 356,721 shares, according to the latest SEC report filing. GMVD stock had 6 new institutional investments in for a total of 90,156 shares, while 3 institutional investors sold positions of 121,775 shares during the same period.